Krsnaa Diagnostics Ltd

Krsnaa Diagnostics Ltd witnessed a sharp gap down at the opening of trade on 30 Mar 2026, reflecting heightened market apprehension. The stock opened with an 8.49% decline, hitting a new 52-week low of Rs.502.2, continuing its recent downward trajectory amid persistent volatility and sector underperformance.

A sharp decline in Krsnaa Diagnostics Ltd has pushed the stock to a fresh 52-week low of Rs 502.2 on 30 Mar 2026, marking a significant 7.63% drop over the last two sessions and underperforming its sector by nearly 2% today. This downturn comes amid a broader market weakness, with the Sensex itself trading close to its own 52-week low.

Krsnaa Diagnostics Ltd’s share price declined sharply on 27 Mar 2026, touching a new 52-week low of Rs.543.6. This marks a significant drop for the healthcare services company, reflecting ongoing pressures both within the stock and the wider market environment.

Krsnaa Diagnostics Ltd is rated Sell by MarketsMOJO, with this rating last updated on 06 February 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 25 March 2026, providing investors with the latest insights into its performance and outlook.

For the fourth consecutive session, Krsnaa Diagnostics Ltd has closed lower, culminating in a fresh 52-week low of Rs 565.05 on 24 Mar 2026. This marks a 6.5% decline over the past four days, underscoring persistent selling pressure despite an intraday high of Rs 588.10 today.

For the third consecutive session, Krsnaa Diagnostics Ltd has declined, culminating in a fresh 52-week low of Rs 577 on 23 Mar 2026. This marks a 35.3% drop from its 52-week high of Rs 891.8, reflecting sustained selling pressure despite a sector that has also faced headwinds.

For the third consecutive session, Krsnaa Diagnostics Ltd has declined, culminating in a fresh 52-week low of Rs 577 on 23 Mar 2026. This drop comes despite some pockets of financial improvement, highlighting a complex interplay of factors weighing on the stock.

Krsnaa Diagnostics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 06 February 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 14 March 2026, providing investors with the latest insights into its performance and outlook.

Krsnaa Diagnostics Ltd’s shares declined sharply to a fresh 52-week low of Rs.581 on 9 Mar 2026, marking a significant downturn amid broader market weakness and company-specific headwinds. The stock has underperformed its sector and benchmark indices, reflecting ongoing concerns about its recent financial performance and investor participation.

Krsnaa Diagnostics Ltd’s stock declined to a fresh 52-week low of Rs.617.4 today, marking a significant price level amid continued downward momentum. The stock has underperformed its sector and broader market indices, reflecting a series of financial and market-related factors influencing its valuation.

Krsnaa Diagnostics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 06 February 2026. However, the analysis and financial metrics discussed below reflect the stock's current position as of 03 March 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Krsnaa Diagnostics Ltd, a key player in the Healthcare Services sector, has reached a new 52-week low of Rs.620.35, marking a significant decline in its stock price amid a challenging market environment. The stock’s recent performance reflects a continuation of downward momentum, with notable financial and market factors contributing to this development.

Krsnaa Diagnostics Ltd, a player in the healthcare services sector, has touched a fresh 52-week low of Rs.621.3 today, marking a significant decline amid a sustained downward trend. The stock has underperformed its sector and broader market indices, reflecting a challenging period for the company’s share price.

Krsnaa Diagnostics Ltd’s share price declined to a fresh 52-week low of Rs.626.15 today, marking a significant milestone in its ongoing downward trajectory. The stock has underperformed its sector and broader market indices, reflecting a series of financial and market pressures that have weighed on investor sentiment over the past year.

Krsnaa Diagnostics Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 06 February 2026. However, the analysis below reflects the stock's current position as of 20 February 2026, incorporating the latest fundamentals, returns, and financial metrics to provide investors with an up-to-date perspective.

Krsnaa Diagnostics Ltd has witnessed a notable improvement in its valuation parameters, shifting from an attractive to a very attractive rating. This change reflects a significant recalibration in price-to-earnings and price-to-book value metrics relative to its historical averages and peer group, suggesting a more compelling entry point for investors despite recent stock underperformance.

Krsnaa Diagnostics Ltd has seen its investment rating upgraded from Strong Sell to Sell as of 6 February 2026, reflecting a nuanced shift in its financial quality and valuation metrics despite ongoing challenges in its quarterly financial performance and market returns. This article analyses the four key parameters—Quality, Valuation, Financial Trend, and Technicals—that influenced this change, providing investors with a comprehensive understanding of the company’s current standing within the healthcare services sector.

Krsnaa Diagnostics Ltd has seen its quality rating upgraded from average to good, reflecting notable improvements in its business fundamentals. This shift comes amid a challenging market backdrop where the stock has underperformed the Sensex over the past year but outpaced it over the medium term. Investors should carefully analyse the company’s enhanced return ratios, debt metrics, and operational consistency to understand the implications of this upgrade.